Evaluation of microRNAs regulating anoikis pathways and its therapeutic potential

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Malagobadan, Sharan ^a   Nagoor, Noor Hasima ^a,b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RNA;

ANOIKIS; CANCER GROWTH; CELL SURVIVAL; EVALUATION STUDY; HUMAN; METASTASIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; ANOIKIS; CELL SURVIVAL; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; RNA, NEOPLASM;

EID: 84947583554     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/716816     Document Type: Review

References (90)

1. J. Rosenblatt, M. C. Raf, and L. P. Cramer, "An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin-and myosin-dependent mechanism," Current Biology, vol. 11, no. 23, pp. 1847-1857, 2001.
2. S. M. Frisch and H. Francis, "Disruption of epithelial cell-matrix interactions induces apoptosis," Journal of Cell Biology, vol. 124, no. 4, pp. 619-626, 1994.
3. C. L. Buchheit, K. J. Weigel, and Z. T. Schafer, "Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression," Nature Reviews Cancer, vol. 14, no. 9, pp. 632-641, 2014.
4. S. M. Frisch and R. A. Screaton, "Anoikis mechanisms," Current Opinion in Cell Biology, vol. 13, no. 5, pp. 555-562, 2001.
5. A. E. Li, H. Ito, I. I. Rovira et al., "A role for reactive oxygen species in endothelial cell anoikis," Circulation Research, vol. 85, no. 4, pp. 304-310, 1999.
6. M. C. Guadamillas, A. Cerezo, and M. A. del Pozo, "Overcoming anoikis-pathways to anchorageindependent growth in cancer," Journal of Cell Science, vol. 124, no. 19, pp. 3189-3197, 2011.
7. C. D. Simpson, K. Anyiwe, and A. D. Schimmer, "Anoikis resistance and tumor metastasis," Cancer Letters, vol. 272, no. 2, pp. 177-185, 2008.
8. P. Chiarugi and E. Giannoni, "Anoikis: a necessary death program for anchorage-dependent cells," Biochemical Pharmacology, vol. 76, no. 11, pp. 1352-1364, 2008.
9. Y.-N. Kim, K. H. Koo, J. Y. Sung, U.-J. Yun, and H. Kim, "Anoikis resistance: an essential prerequisite for tumor metastasis," International Journal of Cell Biology, vol. 2012, Article ID 306879, 11 pages, 2012.
10. J. S. Desgrosellier and D. A. Cheresh, "Integrins in cancer: biological implications and therapeutic opportunities," Nature Reviews Cancer, vol. 10, no. 1, pp. 9-22, 2010.
11. 1B integrin isoform in caspase-8-dependent integrin-mediated keratinocyte death," Journal of Investigative Dermatology, vol. 130, no. 11, pp. 2569-2577, 2010.
12. D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh, "Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins," Journal of Cell Biology, vol. 155, no. 4, pp. 459-470, 2001.
13. A. Ratheesh and A. S. Yap, "A bigger picture: classical cadherins and the dynamic actin cytoskeleton," Nature Reviews Molecular Cell Biology, vol. 13, no. 10, pp. 673-679, 2012.
14. M. Lu, S. Marsters, X. Ye, E. Luis, L. Gonzalez, and A. Ashkenazi, "E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis," Molecular Cell, vol. 54, no. 6, pp. 987-998, 2014.
15. J. Grossmann, "Molecular mechanisms of 'detachment-induced apoptosis-Anoikis'," Apoptosis, vol. 7, no. 3, pp. 247-260, 2002.
16. E. M. Kovacs, R. G. Ali, A. J. McCormack, and A. S. Yap, "E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts," The Journal of Biological Chemistry, vol. 277, no. 8, pp. 6708-6718, 2002.
17. J. L. Luebke-Wheeler, G. Nedredal, L. Yee, B. P. Amiot, and S. L. Nyberg, "E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism," Cell Transplantation, vol. 18, no. 12, pp. 1281-1287, 2009.
18. T. T. Onder, P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander, and R. A. Weinberg, "Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways," Cancer Research, vol. 68, no. 10, pp. 3645-3654, 2008.
19. G. Li, K. Satyamoorthy, and M. Herlyn, "N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells," Cancer Research, vol. 61, no. 9, pp. 3819-3825, 2001.
20. L.-B. Weiswald, S. Richon, G. Massonnet et al., "A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation," British Journal of Cancer, vol. 108, no. 8, pp. 1720-1731, 2013.
21. S. K. Hindupur, S. A. Balaji, M. Saxena et al., "Identifcation of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells," Breast Cancer Research, vol. 16, no. 4, article 420, 2014.
22. L.-B. Weiswald, S. Richon, P. Validire et al., "Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness," British Journal of Cancer, vol. 101, no. 3, pp. 473-482, 2009.
23. M. D. Jansson and A. H. Lund, "MicroRNA and cancer," Molecular Oncology, vol. 6, no. 6, pp. 590-610, 2012.
24. L. P. Lim, N. C. Lau, P. Garrett-Engele et al., "Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs," Nature, vol. 433, no. 7027, pp. 769-773, 2005.
25. A. Krek, D. Grün, M. N. Poy et al., "Combinatorial microRNA target predictions," Nature Genetics, vol. 37, no. 5, pp. 495-500, 2005.
26. L. Zhang, X. Wang, and P. Chen, "MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells," BMC Cancer, vol. 13, article 290, 2013.
27. D. R. Alessi, K. Sakamoto, and J. R. Bayascas, "LKB1-dependent signaling pathways," Annual Review of Biochemistry, vol. 75, pp. 137-163, 2006.
28. H. Cheng, P. Liu, Z. C. Wang et al., "SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis," Science Signaling, vol. 2, no. 80, article ra35, 2009.
29. Y. Wang, W. Li, X. Zang et al., "MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacifcation by targeting SMAD4," Investigative Ophthalmology & Visual Science, vol. 54, no. 1, pp. 323-332, 2013.
30. X. Yang, L. Liang, X.-F. Zhang et al., "MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway," Hepatology, vol. 58, no. 1, pp. 158-170, 2013.
31. X. Yang, X.-F. Zhang, X. Lu et al., "MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway," Hepatology, vol. 59, no. 5, pp. 1874-1885, 2014.
32. X. Zhang, S.-L. Cheng, K. Bian et al., "MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin," Oncotarget, vol. 6, no. 4, pp. 2277-2289, 2015.
33. L. Wu, J. A. Bernard-Triflo, Y. Lim et al., "Distinct FAK-Src activation events promote β5β1 and β4β1 integrin-stimulated neuroblastoma cell motility," Oncogene, vol. 27, no. 10, pp. 1439-1448, 2008.
34. S. Valastyan, F. Reinhardt, N. Benaich et al., "A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis," Cell, vol. 137, no. 6, pp. 1032-1046, 2009.
35. O. Goundiam, M.-D. Nagel, and M. Vayssade, "Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells," Cell Biology International, vol. 36, no. 3, pp. 311-319, 2012.
36. S. Miyaki, T. Sato, A. Inoue et al., "MicroRNA-140 plays dual roles in both cartilage development and homeostasis," Genes and Development, vol. 24, no. 11, pp. 1173-1185, 2010.
37. K. Smigielska-Czepiel, A. van den Berg, P. Jellema et al., "Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells," PLoS ONE, vol. 8, no. 10, Article ID e76217, 2013.
38. Y. Nan, L. Han, A. Zhang et al., "MiRNA-451 plays a role as tumor suppressor in human glioma cells," Brain Research, vol. 1359, pp. 14-21, 2010.
39. Y. Tian, Y. Nan, L. Han et al., "MicroRNA miR-451 downregu-lates the PI3K/AKT pathway through CAB39 in human glioma," International Journal of Oncology, vol. 40, no. 4, pp. 1105-1112, 2012.
40. J. Boudeau, A. F. Baas, M. Deak et al., "MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm," The EMBO Journal, vol. 22, no. 19, pp. 5102-5114, 2003.
41. R. Tao, J. Gong, X. Luo et al., "AMPK exerts dual regulatory efects on the PI3K pathway," Journal of Molecular Signaling, vol. 5, no. 1, p. 1, 2010.
42. X.-C. Wang, L.-L. Tian, X.-Y. Jiang et al., "The expression and function of miRNA-451 in non-small cell lung cancer," Cancer Letters, vol. 311, no. 2, pp. 203-209, 2011.
43. X. Zhang, B. Zhang, J. Gao, X. Wang, and Z. Liu, "Regulation of the MicroRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein afects expression of Pin1 protein to control anoikis," The Journal of Biological Chemistry, vol. 288, no. 45, pp. 32742-32752, 2013.
44. D. R. Cochrane, E. N. Howe, N. S. Spoelstra, and J. K. Richer, "Loss of miR-200c: a marker of aggressiveness and chemoresis-tance in female reproductive cancers," Journal of Oncology, vol. 2010, Article ID 821717, 12 pages, 2010.
45. E. N. Howe, D. R. Cochrane, and J. K. Richer, "Targets of miR-200c mediate suppression of cell motility and anoikis resistance," Breast Cancer Research, vol. 13, no. 2, article R45, 2011.
46. R. Tejero, A. Navarro, M. Campayo et al., "miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma," PLoS ONE, vol. 9, no. 7, Article ID e101899, 2014.
47. Y. Zhang, T. Li, P. Guo et al., "MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression," Scientifc Reports, vol. 4, article 6248, 2014.
48. L. Li, Z. Li, X. Kong et al., "Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and beta-catenin signaling in pancreatic ductal adenocarcinoma cells," Gastroenterology, vol. 147, no. 2, pp. 485.e18-497.e18, 2014.
49. X. Yu, D. M. Cohen, and C. S. Chen, "miR-125b is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis," Stem Cells, vol. 30, no. 5, pp. 956-964, 2012.
50. M. A. Taylor, K. Sossey-Alaoui, C. L. Tompson, D. Danielpour, and W. P. Schiemann, "TGF-β upregulates miR-181a expression to promote breast cancer metastasis," The Journal of Clinical Investigation, vol. 123, no. 1, pp. 150-163, 2013.
51. M. F. Derouet, G. Liu, and G. E. Darling, "MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance," PLoS ONE, vol. 9, no. 12, Article ID 0115589, 2014.
52. J. Hao, S. Zhang, Y. Zhou, C. Liu, X. Hu, and C. Shao, "MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer," Biochemical and Biophysical Research Communications, vol. 406, no. 4, pp. 552-557, 2011.
53. K. Jazdzewski, E. L. Murray, K. Franssila, B. Jarzab, D. R. Schoenberg, and A. de la Chapelle, "Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 20, pp. 7269-7274, 2008.
54. H. Zhong, H.-R. Wang, S. Yang et al., "Targeting Smad4 links microRNA-146a to the TGF-β pathway during retinoid acid induction in acute promyelocytic leukemia cell line," International Journal of Hematology, vol. 92, no. 1, pp. 129-135, 2010.
55. B. Xiao, E.-D. Zhu, N. Li et al., "Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis," Oncology Reports, vol. 27, no. 2, pp. 559-566, 2012.
56. Z. Hou, L. Xie, L. Yu, X. Qian, and B. Liu, "MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis," Medical Oncology, vol. 29, no. 2, pp. 886-892, 2012.
57. J. Hao, S. Zhang, Y. Zhou, X. Hu, and C. Shao, "MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer," FEBS Letters, vol. 585, no. 1, pp. 207-213, 2011.
58. T. Bertero, C. Gastaldi, I. Bourget-Ponzio et al., "miR-483-3p controls proliferation in wounded epithelial cells," The FASEB Journal, vol. 25, no. 9, pp. 3092-3105, 2011.
59. Y. Zhang, K.-J. Fan, Q. Sun et al., "Functional screening for miRNAs targeting Smad4 identifed miR-199a as a negative regulator of TGF-β signalling pathway," Nucleic Acids Research, vol. 40, no. 18, pp. 9286-9297, 2012.
60. Y. Liao and M.-C. Hung, "Physiological regulation of Akt activity and stability," American Journal of Translational Research, vol. 2, no. 1, pp. 19-42, 2010.
61. Y. Liao, Y. Wei, X. Zhou et al., "Peptidyl-prolyl cis/trans isom-erase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation," Oncogene, vol. 28, no. 26, pp. 2436-2445, 2009.
62. K. D. Cowden Dahl, R. Dahl, J. N. Kruichak, and L. G. Hudson, "The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells," Neoplasia, vol. 11, no. 11, pp. 1208-1215, 2009.
63. T. A. Harris, M. Yamakuchi, M. Kondo, P. Oettgen, and C. J. Lowenstein, "Ets-1 and Ets-2 regulate the expression of MicroRNA-126 in endothelial cells," Arteriosclerosis, Trombo-sis, and Vascular Biology, vol. 30, no. 10, pp. 1990-1997, 2010.
64. C. J. Tiele, Z. Li, and A. E. McKee, "On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology," Clinical Cancer Research, vol. 15, no. 19, pp. 5962-5967, 2009.
65. S. Douma, T. Van Laar, J. Zevenhoven, R. Meuwissen, E. Van Garderen, and D. S. Peeper, "Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB," Nature, vol. 430, no. 7003, pp. 1034-1039, 2004.
66. Z. Weng, M. Xin, L. Pablo et al., "Protection against anoikis and down-regulation of cadherin expression by a regulatable β-catenin protein," Journal of Biological Chemistry, vol. 277, no. 21, pp. 18677-18686, 2002.
67. J. B ehrens, J. P. von Kries, M. Kühl et al., "Functional interaction of β-catenin with the transcription factor LEF-1," Nature, vol. 382, no. 6592, pp. 638-642, 1996.
68. O. Huber, R. Korn, J. McLaughlin, M. Ohsugi, B. G. Herrmann, and R. Kemler, "Nuclear localization of β-catenin by interaction with transcription factor LEF-1," Mechanisms of Development, vol. 59, no. 1, pp. 3-10, 1996.
69. N. Zhang, P. Wei, A. Gong et al., "FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis," Cancer Cell, vol. 20, no. 4, pp. 427-442, 2011.
70. Y. Yin, Y.-X. Llu, Y. J. Jin, E. J. Hall, and J. C. Barrett, "PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression," Nature, vol. 422, no. 6931, pp. 527-531, 2003.
71. M. A. Nikiforov, K. Hagen, V. S. Ossovskaya et al., "p53 modulation of anchorage independent growth and experimental metastasis," Oncogene, vol. 13, no. 8, pp. 1709-1719, 1996.
72. M. Vitale, T. Di Matola, M. Bifulco, A. Casamassima, G. Fenzi, and G. Rossi, "Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression," FEBS Letters, vol. 462, no. 1-2, pp. 57-60, 1999.
73. Y. Wang, Y. Yu, A. Tsuyada et al., "Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM," Oncogene, vol. 30, no. 12, pp. 1470-1480, 2011.
74. 1-integrin regulates ovarian cancer invasion and metastasis," Oncogene, vol. 30, no. 13, pp. 1566-1576, 2011.
75. S. Volinia, G. A. Calin, C.-G. Liu et al., "A microRNA expression signature of human solid tumors defnes cancer gene targets," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
76. X. Wang, S. Tang, S.-Y. Le et al., "Aberrant expression of onco-genic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth," PLoS ONE, vol. 3, no. 7, Article ID e2557, 2008.
77. B. N. Davis, A. C. Hilyard, G. Lagna, and A. Hata, "SMAD proteins control DROSHA-mediated microRNA maturation," Nature, vol. 454, no. 7200, pp. 56-61, 2008.
78. Cancer Genome Atlas Research Network, "Comprehensive genomic characterization defnes human glioblastoma genes and core pathways," Nature, vol. 455, no. 7216, pp. 1061-1068, 2008.
79. Y. Samuels, Z. Wang, A. Bardelli et al., "High frequency of mutations of the PIK3CA gene in human cancers," Science, vol. 304, no. 5670, p. 554, 2004.
80. E. Ciraolo, F. Morello, and E. Hirsch, "Present and future of PI3K pathway inhibition in cancer: perspectives and limitations," Current Medicinal Chemistry, vol. 18, no. 18, pp. 2674-2685, 2011.
81. S.-M. Maira, "PI3K inhibitors for cancer treatment: fve years of preclinical and clinical research afer BEZ235," Molecular Cancer Terapeutics, vol. 10, no. 11, p. 2016, 2011.
82. S. A. Hahn, M. Schutte, A. T. M. Shamsul Hoque et al., "DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1," Science, vol. 271, no. 5247, pp. 350-353, 1996.
83. B. Schmierer and C. S. Hill, "TGFβ-SMAD signal transduction: molecular specifcity and functional fexibility," Nature Reviews Molecular Cell Biology, vol. 8, no. 12, pp. 970-982, 2007.
84. X.-H. Feng, Y. Zhang, R.-Y. Wu, and R. Derynck, "The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced tran-scriptional activation," Genes & Development, vol. 12, no. 14, pp. 2153-2163, 1998.
85. D. Horbelt, A. Denkis, and P. Knaus, "A portrait of Transforming Growth Factor β superfamily signalling: background matters," International Journal of Biochemistry and Cell Biology, vol. 44, no. 3, pp. 469-474, 2012.
86. M. Ramachandra, I. Atencio, A. Rahman et al., "Restoration of transforming growth factor β signaling by functional expression of Smad4 induces anoikis," Cancer Research, vol. 62, no. 21, pp. 6045-6051, 2002.
87. S. Kagami, T. Kuhara, K. Yasutomo et al., "Transforming growth factor-β (TGF-β) stimulates the expression of β1 integrins and adhesion by rat mesangial cells," Experimental Cell Research, vol. 229, no. 1, pp. 1-6, 1996.
88. P. Hydbring and G. Badalian-Very, "Clinical applications of microRNAs," F1000Research, vol. 2, article 136, 2013.
89. Z. Li and T. M. Rana, "Terapeutic targeting of microRNAs: current status and future challenges," Nature Reviews Drug Discovery, vol. 13, no. 8, pp. 622-638, 2014.
90. X. J. Li, Z. J. Ren, and J. H. Tang, "MicroRNA-34a: a potential therapeutic target in human cancer," Cell Death & Disease, vol. 5, no. 7, Article ID e1327, 2014.